213 related articles for article (PubMed ID: 26045139)
1. Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
Zhao XL; Yang JR; Lin SZ; Ma H; Guo F; Yang RF; Zhang HH; Han JC; Wei L; Pan XB
Gut; 2016 Mar; 65(3):502-11. PubMed ID: 26045139
[TBL] [Abstract][Full Text] [Related]
2. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.
Datta S; Roychoudhury S; Ghosh A; Dasgupta D; Ghosh A; Chakraborty BC; Ray S; Gupta S; Santra AK; Datta S; Das K; Dhali GK; Chowdhury A; Banerjee S
PLoS One; 2014; 9(7):e102573. PubMed ID: 25032957
[TBL] [Abstract][Full Text] [Related]
3. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
4. Conservation and variability of hepatitis B core at different chronic hepatitis stages.
Yll M; Cortese MF; Guerrero-Murillo M; Orriols G; Gregori J; Casillas R; González C; Sopena S; Godoy C; Vila M; Tabernero D; Quer J; Rando A; Lopez-Martinez R; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2020 May; 26(20):2584-2598. PubMed ID: 32523313
[TBL] [Abstract][Full Text] [Related]
5. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma.
Datta S; Dasgupta D; Ghosh A; Ghosh S; Manna A; Datta S; Chatterjee M; Chowdhury A; Banerjee S
Carcinogenesis; 2018 Feb; 39(2):283-292. PubMed ID: 29228221
[TBL] [Abstract][Full Text] [Related]
7. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
8. Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.
Lu X; Xu Q; Bu X; Ma X; Zhang F; Deng Q; Zhang Y; Ding J
Int J Clin Exp Pathol; 2014; 7(9):6048-55. PubMed ID: 25337250
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
10. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
13. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
[TBL] [Abstract][Full Text] [Related]
14. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
Cai X; Peng S; Xiao X; Huang Z; Zhang P
Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
[TBL] [Abstract][Full Text] [Related]
15. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
16. Changes in Red Blood Cell Distribution Width is Associated with Liver Function Parameters and Prognosis in Patients with Chronic HBV Liver Disease.
Kai Y; Zishu G; Shihe G; Yufeng G; Qiang Z
Clin Lab; 2016 Nov; 62(11):2197-2202. PubMed ID: 28164679
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
18. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian CH; Dai J; Zhang W; Liu Y; Yang Y
Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
[TBL] [Abstract][Full Text] [Related]
19. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
[TBL] [Abstract][Full Text] [Related]
20. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
